Sun.Jan 12, 2025

article thumbnail

Intellia slashes workforce by 27% to focus on late stage CRISPR candidates

Pharmaceutical Technology

Intellia expects to incur charges of $8m associated with the reorganisation, which will likely be incurred in Q1 2025.

246
246
article thumbnail

Tune raises $175M for hepatitis B medicine, epigenetic research

Bio Pharma Dive

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat chronic hepatitis B infections.

Medicine 210
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Antiviral Medications for Treatment of Nonsevere Influenza

JAMA Internal Medicine

This systematic review and network meta-analysis evaluates the effectiveness and safety of antiviral treatment for patients with nonsevere influenza and thus support an update of World Health Organization guidelines on antiviral treatment for influenza.

111
111
article thumbnail

FDA’s Issues Draft Guidance on Accelerated Approval: A Substantial Evidentiary and Procedural Overhaul to this High-Profile Pathway

FDA Law Blog

By Charles G. Raver & James E. Valentine & Ellis Unger & Frank J. Sasinowski On December 5, 2024, FDA published a new draft guidance on accelerated approval providing a much needed and substantial update to its guidance on the pathway. FDAs application and use of accelerated approval has evolved dramatically since it was first developed by the Agency to help address the HIV/AIDS epidemic in the late 1980s.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

The Evolving Case for Skin Failure—Beyond Pressure Injury

JAMA Internal Medicine

This Viewpoint discusses the concept of skin failure, the breakdown of skin in aging and critically ill patients; how it differs from pressure injury; and future areas of research regarding the process.